TrialEuropean journal of nuclear medicine and molecular imaging2018

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Paola Caroli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.